Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue plus ropivacaine for postoperative analgesia after iliac crest grafting in alveolar cleft
ChiCTR2400080483Phase 4Not yet recruiting
- Sponsor
- Plastic Surgery Hospital of Chinese Academy of Medical Sciences
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cleft alveolus comparing Methylene blue + ropivacaine arm with Ropivacaine alone arm (2 arms). Primary endpoint: Postoperative pain intensity (VAS). Planned start Jan 2024; status: not yet recruiting.
02
Drugs
methylene blueropivacaine
03
Conditions
cleft alveolus
Beyond the preview
Go deeper on ChiCTR2400080483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080483.